"Pancreatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Descriptor ID |
D010190
|
| MeSH Number(s) |
C04.588.274.761 C04.588.322.475 C06.301.761 C06.689.667 C19.344.421
|
| Concept/Terms |
Pancreatic Neoplasms- Pancreatic Neoplasms
- Neoplasm, Pancreatic
- Pancreatic Neoplasm
- Pancreas Neoplasms
- Neoplasm, Pancreas
- Neoplasms, Pancreas
- Pancreas Neoplasm
- Neoplasms, Pancreatic
Cancer of Pancreas- Cancer of Pancreas
- Pancreas Cancers
- Pancreas Cancer
- Cancer, Pancreas
- Cancers, Pancreas
- Pancreatic Cancer
- Cancer, Pancreatic
- Cancers, Pancreatic
- Pancreatic Cancers
- Cancer of the Pancreas
|
Below are MeSH descriptors whose meaning is more general than "Pancreatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pancreatic Neoplasms".
This graph shows the total number of publications written about "Pancreatic Neoplasms" by people in this website by year, and whether "Pancreatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 0 | 3 |
| 1998 | 7 | 1 | 8 |
| 1999 | 3 | 0 | 3 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 0 | 2 |
| 2002 | 3 | 1 | 4 |
| 2003 | 3 | 1 | 4 |
| 2004 | 5 | 0 | 5 |
| 2005 | 17 | 0 | 17 |
| 2006 | 10 | 2 | 12 |
| 2007 | 13 | 2 | 15 |
| 2008 | 13 | 2 | 15 |
| 2009 | 22 | 2 | 24 |
| 2010 | 16 | 4 | 20 |
| 2011 | 26 | 4 | 30 |
| 2012 | 16 | 2 | 18 |
| 2013 | 20 | 1 | 21 |
| 2014 | 14 | 3 | 17 |
| 2015 | 12 | 0 | 12 |
| 2016 | 19 | 2 | 21 |
| 2017 | 21 | 2 | 23 |
| 2018 | 25 | 4 | 29 |
| 2019 | 25 | 1 | 26 |
| 2020 | 23 | 0 | 23 |
| 2021 | 23 | 0 | 23 |
| 2022 | 17 | 0 | 17 |
| 2023 | 22 | 1 | 23 |
| 2024 | 11 | 3 | 14 |
| 2025 | 20 | 0 | 20 |
| 2026 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pancreatic Neoplasms" by people in Profiles.
-
Pancreatic Cancer Risk in Patients With Low-Risk Cystic Lesions. JAMA Netw Open. 2026 May 01; 9(5):e2613808.
-
Alprazolam Reduces Inflammatory Cytokine Production in Pancreatic Cancer-Associated Fibroblasts. Cancer Res Commun. 2026 May 01; 6(5):1048-1060.
-
A digital quality measure for emergency presentation of pancreatic cancer. Br J Cancer. 2026 Apr; 134(8):1209-1217.
-
Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth. Mol Cancer Ther. 2026 Feb 04; 25(2):257-271.
-
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial. Nat Med. 2026 Jan; 32(1):258-269.
-
KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer. Cancer Res. 2025 Dec 01; 85(23):4825-4838.
-
The canonical ER stress IRE1a/XBP1 pathway mediates skeletal muscle wasting during pancreatic cancer cachexia. EMBO Mol Med. 2025 Dec; 17(12):3607-3635.
-
Re/99mTc Tricarbonyl Phenformin Complexes Targeting Mitochondria as Pancreatic Cancer Theranostics. J Med Chem. 2025 Nov 13; 68(21):22818-22830.
-
RALGEF inhibitors suppress RAS-driven pancreatic cancer and metastasis. J Biol Chem. 2025 12; 301(12):110809.
-
Engineered exosomes with KrasG12D specific siRNA in pancreatic cancer: a phase I study with immunological correlates. Nat Commun. 2025 Sep 30; 16(1):8696.